Cellectar Biosciences Inc

NASDAQ:CLRB  
2.05
-0.28 (-12.02%)
4:14:21 PM EDT: $2.04 -0.01 (-0.49%)
Earnings Announcements

Cellectar Reports Q3 Loss Per Share Of $0.15

Published: 11/09/2020 13:58 GMT
Cellectar Biosciences Inc (CLRB) - Cellectar Reports Third Quarter 2020 Financial Results and Provides a Corporate Update.
Q3 Loss per Share $0.15.
Q3 Earnings per Share Estimate $-0.20 -- Refinitiv Ibes Data (analyst estimates).
As of September 30, 2020, Company Had Cash and Cash Equivalents of $18.8 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.